Reports
Reports
Sale
The global unna boot market size was valued at USD 122.7 million in 2023, driven by the rising prevalence of venous leg ulcers across the globe. The market is expected to grow at a CAGR of 5.07% during the forecast period of 2024-2032, with the values likely to rise from USD 128.9 million in 2024 to USD 191.4 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Unna boot is a gauze bandage impregnated with glycerine, zinc oxide, and calamine lotion. As an inelastic compression therapy, it works by increasing compression and providing venous support, aiding the healing of the ulcer. Unna boots find their application across several medical domains including wound care. It provides improvement in comfort, granulation tissue formation, and cost savings when compared to other compression therapies.
Venous leg ulcers are the most commonly occurring leg ulcers, accounting for 70% of all cases. Unna boots are widely used as a compression therapy in reducing venous hypertension and preventing edema. Consequently, the unna boot market growth is likely to increase in upcoming years. It is also used in combination with other treatments such as topical corticosteroids to treat various dermatological conditions including eczema and other inflammatory skin diseases. Furthermore, a significant segment of the geriatric population is likely to adopt unna boot in the coming years which will also increase the market demand.
The market is further driven by a surge in accidents and sports related injuries. According to the data published in Injury Prevention (BMJ Journals) it was revealed that around 5.40 sports or trauma related injuries occurred in every 100,000 participants. Conducted in England and Wales population, the incidence rate was found to be 6.44 per 100,000 in men and 3.34 per 100,000 in women. Unna boots are helpful in protecting the wound site and keep it moisture and itch-free as well. Consequently, the rise in prevalence of injuries is anticipated to boost the unna boot market share in the forecast period.
Rise in Venous Leg Ulcer Cases to Drive Market Growth
Chronic venous insufficiency and venous hypertension are the leading causes of venous leg ulcers (VLU), representing a prominent clinical challenge for both developed and developing economies. It affects the lower limbs and accounts for 60-80% of all leg ulceration. The prevalence rate is reported to be around 1.08%. In addition, it was revealed that the prevalence and incidence of VLUs increase with age, representing a significant social and economic burden, estimated to cost USD 3 billion in the United States annually. As the number of patients with VLUs continues to rise, the unna boot market demand is poised to grow to provide compression to the affected leg.
Cost-Effective Alternative for Treating Venous Ulcers
Unna boot dressing represents a low-cost alternative to wound healing, especially in the management of venous leg ulcers (VLU). The high prevalence and chronicity of venous ulcers necessitate the demand for effective and cost-saving treatment solutions. In March 2023, a study published in Revista Latino-Americana de Enfermagem (RLAE) analyzed the cost-effectiveness of compressive therapies including unna boot therapy to heal venous ulcers. According to the quantitative study, unna boot stood as the second most cost-effective alternative in the healing of venous ulcers. In Brazil, unna boot dressing was the most commonly used method as an inelastic therapy. Thus, the affordability of unna boot is attributed to its dominance in the compressive therapies market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Unna Boot Market Segmentation
Market Breakup by Application
Market Breakup by Raw Material
Market Breakup by Distribution Channel
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America accounts for a significant share of the unna boot market due to the rising prevalence of eczema, venous leg ulcers, and lymphedema in the region. The latest data released by the National Eczema Association shows that 10.1% of the population in the United States which is equivalent to 31.6 million individuals are affected by some type of eczema. Moreover, it is estimated that 1 in 10 people will develop the condition in their lifetime, which is expected to elevate the unna boot market size in the forecast period. In addition, the market growth can be attributed to the high awareness among patients, the dedication of caregivers, and the advanced healthcare infrastructure.
Europe holds a substantial portion of the market share which can be attributed to the presence of major research institutes and leading healthcare companies in the region. Asia Pacific is also predicted to witness notable growth in the unna boot market in the coming years, owing to the large geriatric population base and the increased healthcare expenditure to improve patient outcomes.
One of the major market trends is significant investments made by the key market players to expand their manufacturing and distribution capacities. In December 2023 , a leading United States-based healthcare company known for its innovative Unna boot compression bandages, Medline Industries Inc., announced an additional investment worth USD 300 million to support its Healthcare Resilience Initiative that already boasted a USD 2 billion investment. The funding will help meet the growing supply chain needs and will ensure the delivery of superior clinical solutions and medical supplies.
The key features of the unna boot market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Application |
|
Breakup by Raw Material |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Unna Boot Market Overview
3.1 Global Unna Boot Market Historical Value (2017-2023)
3.2 Global Unna Boot Market Forecast Value (2024-2032)
4 Global Unna Boot Market Landscape*
4.1 Global Unna Boot Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Unna Boot Product Landscape
4.2.1 Analysis by Application
4.2.2 Analysis by Raw Material
5 Global Unna Boot Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Unna Boot Market Segmentation (2017-2032)
6.1 Global Unna Boot Market (2017-2032) by Application
6.1.1 Market Overview
6.1.2 Venous Leg Ulcers
6.1.3 Lymphedema
6.1.4 Eczema
6.2 Global Unna Boot Market (2017-2032) by Raw Material
6.2.1 Market Overview
6.2.2 Zinc Oxide
6.2.3 Zinc
6.2.4 Calamine
6.3 Global Unna Boot Market (2017-2032) by Distribution Channel
6.3.1 Market Overview
6.3.2 Offline Retail
6.3.3 Online Retail
6.4 Global Unna Boot Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Unna Boot Market (2017-2032)
7.1 North America Unna Boot Market (2017-2032) by Application
7.1.1 Market Overview
7.1.2 Venous Leg Ulcers
7.1.3 Lymphedema
7.1.4 Eczema
7.2 North America Unna Boot Market (2017-2032) by Raw Material
7.2.1 Market Overview
7.2.2 Zinc Oxide
7.2.3 Zinc
7.2.4 Calamine
7.3 North America Unna Boot Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Unna Boot Market (2017-2032)
8.1 Europe Unna Boot Market (2017-2032) by Application
8.1.1 Market Overview
8.1.2 Venous Leg Ulcers
8.1.3 Lymphedema
8.1.4 Eczema
8.2 Europe Unna Boot Market (2017-2032) by Raw Material
8.2.1 Market Overview
8.2.2 Zinc Oxide
8.2.3 Zinc
8.2.4 Calamine
8.3 Europe Unna Boot Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Unna Boot Market (2017-2032)
9.1 Asia Pacific Unna Boot Market (2017-2032) by Application
9.1.1 Market Overview
9.1.2 Venous Leg Ulcers
9.1.3 Lymphedema
9.1.4 Eczema
9.2 Asia Pacific Unna Boot Market (2017-2032) by Raw Material
9.2.1 Market Overview
9.2.2 Zinc Oxide
9.2.3 Zinc
9.2.4 Calamine
9.3 Asia Pacific Unna Boot Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America Unna Boot Market (2017-2032)
10.1 Latin America Unna Boot Market (2017-2032) by Application
10.1.1 Market Overview
10.1.2 Venous Leg Ulcers
10.1.3 Lymphedema
10.1.4 Eczema
10.2 Latin America Unna Boot Market (2017-2032) by Raw Material
10.2.1 Market Overview
10.2.2 Zinc Oxide
10.2.3 Zinc
10.2.4 Calamine
10.3 Latin America Unna Boot Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Unna Boot Market (2017-2032)
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape (Customisable)
17.1 Medline Industries, Inc.
17.1.1 Company Overview
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Cardinal Health
17.2.1 Company Overview
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 American Medicals
17.3.1 Company Overview
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Essity Health & Medical
17.4.1 Company Overview
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Convatec Inc.
17.5.1 Company Overview
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 GF Health products, Inc.
17.6.1 Company Overview
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Dynarex Corporation
17.7.1 Company Overview
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 3M
17.8.1 Company Overview
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Baxter
17.9.1 Company Overview
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Pfizer Inc.
17.10.1 Company Overview
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 B. Braun SE
17.11.1 Company Overview
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Paul Hartmann AG
17.12.1 Company Overview
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Molnlycke Health Care AB
17.13.1 Company Overview
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Beiersdorf
17.14.1 Company Overview
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Coloplast Corp
17.15.1 Company Overview
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Unna Boot Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 122.7 million in 2023 driven by the rising prevalence of venous leg ulcers across the globe.
The market is anticipated to grow at a CAGR of 5.07% during the forecast period of 2024-2032, likely to reach a market value of USD 191.4 million by 2032.
The rising awareness about the advantages of unna boots and the surge in the rate of injuries caused by sports or adventures are fuelling the demand for unna boots.
One of the significant trends in the market is the advancement in the healthcare infrastructure and the adoption of cost-effective compression therapies. In March 2023, a study published in Revista Latino-Americana de Enfermagem (RLAE) reported Unna boot as the second most cost-effective alternative in the healing of venous ulcers. In Brazil, Unna boot dressing as an inelastic therapy is the most used method.
Based on the raw material, the market is segmented into zinc oxide, zinc, and calamine.
Major distribution channels of unna boots include offline retail and online retail.
Unna boots are used in the treatment of venous leg ulcers, lymphedema, and eczema.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
Key players involved in the market are Medline Industries, Inc., Cardinal Health, American Medicals, Essity Health & Medical, Convatec Inc., GF Health Products, Inc., Dynarex Corporation, 3M, Baxter, Pfizer Inc., B. Braun SE, Paul Hartmann AG, Molnlycke Health Care AB, Beiersdorf, and Coloplast Corp.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.